Clinical Trials in Phoenix

Showing 8221-8240 of 12,606 trials

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

NCT01397409

This study is conducted in 3 stages. Stage 1 is an open-label, dose-escalation assessment of the safety of AGN-150998 administered as a single intravitreal injection to patients with advanced exudative Age-related Macular Degeneration (AMD). Stage 2 and Stage 3 are randomized, double-masked, comparisons of the safety and treatment effects on retinal edema and best-corrected visual acuity (BCVA) of AGN-150998 and ranibizumab in treatment-naive patients with exudative AMD. Study medication is administered as needed in Stage 2 and with a fixed-dosing schedule in Stage 3. The study objectives are (1) to identify the highest tolerated dose of AGN-150998, (2) to assess the safety and duration of treatment effects on retinal edema and BCVA, and (3) to characterize the systemic pharmacokinetic profile of AGN-150998.

Age-related Macular Degeneration

Allergan271 participantsStarted Sep 2011

Phoenix, Arizona, United States • Sydney, New South Wales, Australia • Vienna, Austria +5 more locations

COMPLETED< 1 mile

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

NCT03208660

This study is conducted to assess the retention rate of Fycompa when given in routine clinical care.

Epilepsy

Eisai Inc.2,000 participantsStarted Apr 2017

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +41 more locations

Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy

Find Trials by Condition in Phoenix

Collecting and Storing Biological Samples From Young Patients With Hodgkin?s Lymphoma

Selonsertib in Adults With Pulmonary Arterial Hypertension

A Study of LY900010 in Erectile Dysfunction

A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose

Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator

Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children

Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations

Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure

Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Dissonance Eating Disorder Prevention: Clinician Led, Peer Led vs Web Delivered

24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis